The blood brain barrier and the role of ratiometric molecular analysis in Schizophrenia

Psychiatry (Edgemont)

Volumn 7, Issue 12, 2010, Pages 20-23

  Yarlagadda, Atmaram ^a   Hampe, Christiane S ^a   Clayton, Anita H ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

NMDA and GAD receptor antibodies; Ratiometic molecular analysis (RMA); S100B; TNF alpha

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; N METHYL DEXTRO ASPARTIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANXIETY; BLOOD BRAIN BARRIER; CALCIUM HOMEOSTASIS; CELL DEATH; CELL SYNCHRONIZATION; CENTRAL NERVOUS SYSTEM; EXCITOTOXICITY; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; FEVER; HEADACHE; HUMAN; ILLNESS BEHAVIOR; MENTAL INSTABILITY; MOLECULAR DYNAMICS; MOTOR DYSFUNCTION; NEUROTRANSMISSION; PREFRONTAL CORTEX; PSYCHOSIS; QUANTITATIVE ANALYSIS; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 79951568613     PISSN: 15505952     EISSN: 15555194     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Yarlagadda A, Clayton AH. Blood brain barrier: the role of pyridoxine. Psychiatry (Edgmont). 2007;4(8):58-60.
2. Yarlagadda A. Role of calcium regulation in pathophysiology model of schizophrenia and possible interventions. Med Hypotheses. 2002;58(2):182-186.
3. Yarlagadda A, Helvink B, Chou C, Clayton AH. Blood brain barrier: The role of GAD antibodies in psychiatry. Psychiatry (Edgmont). 2007;4(6):57-59.
4. Yarlagadda A, Alfson E, Clayton AH. The blood brain barrier and the role of cytokines in neuropsychiatry. Psychiatry (Edgmont). 2009;6(11):18-22.
5. Yarlagadda A, Helvink B, Chou C, Gladieux K, et al. Glutamic acid decarboxylase (GAD) antibodies in tardive dyskinesia (TD) as compared to patients with schizophrenia without TD and normal controls. Schizophr Res. 2008;105(1-3):287-288.
6. Aubert A, Vega C, Dantzer R, Goodall G. Pyrogens specifically disrupt the acquisition of a task involving cognitive processing in the rat. Brain Behav Immun. 1995;9(2):129-148.
7. Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry. 2000;157(5):683-694.
8. Cserr HF, Knopf PM. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol Today. 1992;13(12):507-512.
9. Kambe Y, Nakamichi N, Takarada T, Fukumori R, et al. Induced tolerance to glutamate neurotoxicity through downregulation of NR2 subunits of Nmethyl- D-aspartate receptors in cultured rat striatal neurons. J Neurosci Res. 88(10):2177-2187.
10. Yarlagadda A, Kaushik S, Clayton AH. Blood brain barrier: the role of calcium homeostasis. Psychiatry (Edgmont). 2007;4(12):55-59.
11. Monnerie H, Le Roux PD. Reduced dendrite growth and altered glutamic acid decarboxylase (GAD) 65- and 67-kDa isoform protein expression from mouse cortical GABAergic neurons following excitotoxic injury in vitro. Exp Neurol. 2007;205(2):367-382.
12. Baptista MS, Melo CV, Armelao M, Herrmann D, et al. Role of the proteasome in excitotoxicityinduced cleavage of glutamic acid decarboxylase in cultured hippocampal neurons. PLoS One. 5(4):e10139.
13. Tojima T, Ito E. Bimodal effects of acetylcholine on synchronized calcium oscillation in rat cultured cortical neurons. Neurosci Lett. 2000;287(3):179-182.
14. Yarlagadda A, and Clayton AH. Role of cholinergic system and calcium synchronization in schizophrenia. Psychiatry (Edgmont). 2009;6(4):37-41.
15. Gupta S, Bisht SS, Kukreti R, Jain S, et al. Boolean network analysis of a neurotransmitter signaling pathway. J Theor Biol. 2007;244(3):463-469.
16. Pan W, Xiang S, Tu H, Kastin A. Cytokines interact with the bloodbrain barrier. In: Derietzel R, DCS, Nedergaard M, eds. Blood-Brain Barriers: From Ontogeny to Artificial Interfaces. Weinheim: Wiley-VCH, 2006:247-264.
17. Manda VK, Mittapalli RK, Geldenhuys WJ, Lockman PR. Chronic exposure to nicotine and saquinavir decreases endothelial Notch-4 expression and disrupts blood-brain barrier integrity. J Neurochem. 2010;115(2):515-525.
18. Sen J, Belli A. S100B in neuropathologic states: the CRP of the brain? J Neurosci Res. 2007;85(7):1373-1380.
19. Grigorian A, Hurford R, Chao Y, Patrick C, et al. Alterations in the Notch4 pathway in cerebral endothelial cells by the HIV aspartyl protease inhibitor, nelfinavir. BMC Neurosci. 2008;9:27.
20. Bassitt DP, Louza Neto MR. Clozapine efficacy in tardive dyskinesia in schizophrenic patients. Eur Arch Psychiatry Clin Neurosci. 1998;248(4):209-211.
21. Meyer JM, Marsh J, Simpson G. Differential sensitivities to risperidone and olanzapine in a human immunodeficiency virus patient. Biol Psychiatry. 1998;44(8):791-794.
22. Packer L, Tritschler HJ, Wessel K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic Biol Med. 1997;22(1- 2):359-378.